Authors: Wight, NJ Gottesdiener, K Garlick, NM Atherton, CT Novak, S Gertz, BJ Calder, NA Cote, J Wong, P Dallob, A Hawkey, CJ

Citation: Nj. Wight et al., Rofecoxib, a COX-2 inhibitor, does not inhibit human gastric mucosal prostaglandin production, GASTROENTY, 120(4), 2001, pp. 867-873